PDB Short entry for 1OAK HEADER COMPLEX (WILLEBRAND/IMMUNOGLOBULIN) 18-DEC-97 1OAK TITLE CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 TITLE 2 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: NMC-4 IGG1; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT, AN ANTI VON WILLEBRAND FACTOR COMPND 5 (VWF) A1 DOMAIN; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE ANTIBODY HEAVY CHAIN CONSISTS OF TWO COMPND 8 SEGMENTS, H1 AND H2, BOTH LABELED CHAIN H IN THIS ENTRY; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NMC-4 IGG1; COMPND 11 CHAIN: H; COMPND 12 FRAGMENT: FAB FRAGMENT, AN ANTI VON WILLEBRAND FACTOR COMPND 13 (VWF) A1 DOMAIN; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: THE ANTIBODY HEAVY CHAIN CONSISTS OF TWO COMPND 16 SEGMENTS, H1 AND H2, BOTH LABELED CHAIN H IN THIS ENTRY; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: VON WILLEBRAND FACTOR; COMPND 19 CHAIN: A; COMPND 20 FRAGMENT: A1 DOMAIN RESIDUES 507 - 702, OR GLYCOPROTEIN COMPND 21 IBA (A\:ALPHA) BINDING DOMAIN; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 CELL_LINE: HYBRIDOMA; SOURCE 6 ORGAN: BLOOD; SOURCE 7 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: MOPC21; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 CELL_LINE: HYBRIDOMA; SOURCE 16 ORGAN: BLOOD; SOURCE 17 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: MOPC21; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 ORGAN: BLOOD; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 28 EXPRESSION_SYSTEM_VECTOR_TYPE: T7 PROMOTER; SOURCE 29 EXPRESSION_SYSTEM_PLASMID: PET8C KEYWDS VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, KEYWDS 2 COMPLEX (WILLEBRAND/IMMUNOGLOBULIN), BLOOD COAGULATION EXPDTA X-RAY DIFFRACTION AUTHOR R.CELIKEL,K.I.VARUGHESE REVDAT 3 24-FEB-09 1OAK 1 VERSN REVDAT 2 01-APR-03 1OAK 1 JRNL REVDAT 1 21-OCT-98 1OAK 0 JRNL AUTH R.CELIKEL,K.I.VARUGHESE,MADHUSUDAN,A.YOSHIOKA, JRNL AUTH 2 J.WARE,Z.M.RUGGERI JRNL TITL CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A1 JRNL TITL 2 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 JRNL TITL 3 FAB. JRNL REF NAT.STRUCT.BIOL. V. 5 189 1998 JRNL REFN ISSN 1072-8368 JRNL PMID 9501911 JRNL DOI 10.1038/NSB0398-189 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.CELIKEL,MADHUSUDAN,K.I.VARUGHESE,M.SHIMA, REMARK 1 AUTH 2 A.YOSHIOKA,J.WARE,Z.M.RUGGERI REMARK 1 TITL CRYSTAL STRUCTURE OF NMC-4 FAB ANTI-VON WILLEBRAND REMARK 1 TITL 2 FACTOR A1 DOMAIN REMARK 1 REF BLOOD CELLS MOL.DIS. V. 23 123 1997 REMARK 1 REFN ISSN 1079-9796 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 44346 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1610 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5241 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 366 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.90000 REMARK 3 B22 (A**2) : -17.30000 REMARK 3 B33 (A**2) : 5.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OAK COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUN-95 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : BENT CYLINDRICAL GE(111) REMARK 200 OPTICS : PT COATED SI FLAT MIRROR BENT REMARK 200 FOR VERTICAL FOCUS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44346 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.18400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 AND MULTIPLE ISOMORPHOUS REPLACEMENT REMARK 200 SOFTWARE USED: PHASES, X-PLOR REMARK 200 STARTING MODEL: NMC4 (FAB) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.10000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.95000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.10000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.95000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 351 REMARK 465 ALA H 352 REMARK 465 ALA H 353 REMARK 465 GLN H 354 REMARK 465 THR H 355 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH L 744 O HOH L 1016 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 916 O HOH A 916 2657 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN L 30 46.54 35.53 REMARK 500 THR L 51 -48.25 69.93 REMARK 500 SER L 56 131.77 -39.29 REMARK 500 ALA L 84 -169.17 -173.24 REMARK 500 THR L 126 1.30 -61.35 REMARK 500 ASN L 138 64.95 34.48 REMARK 500 ASP L 170 -7.80 128.53 REMARK 500 SER L 171 36.69 38.78 REMARK 500 SER H 229 -20.97 68.91 REMARK 500 SER H 290 51.57 36.99 REMARK 500 ALA H 305 172.44 177.28 REMARK 500 THR H 339 95.11 -44.29 REMARK 500 PRO H 349 151.43 -31.18 REMARK 500 PHE H 369 139.49 -178.13 REMARK 500 SER H 383 -46.27 -139.72 REMARK 500 SER H 395 75.73 -176.77 REMARK 500 ASP H 396 11.19 56.11 REMARK 500 ALA H 424 -18.30 -48.22 REMARK 500 TRP A 550 -106.84 -130.33 REMARK 500 HIS A 559 -114.96 -126.44 REMARK 500 GLN A 604 -66.37 -105.13 REMARK 500 ASN A 658 97.92 -59.76 REMARK 500 REMARK 500 REMARK: NULL DBREF 1OAK L 9 208 GB 1890296 AAB49725 1 200 DBREF 1OAK H 223 432 GB 1890294 AAB49724 1 210 DBREF 1OAK A 508 702 UNP P04275 VWF_HUMAN 1271 1465 SEQRES 1 L 212 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 L 212 SER LEU GLY ASP ARG VAL THR ILE SER CYS SER ALA SER SEQRES 3 L 212 GLN ASP ILE ASN LYS TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 L 212 PRO ASP GLY ALA VAL LYS LEU LEU ILE PHE TYR THR SER SEQRES 5 L 212 SER LEU HIS SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 212 GLY SER GLY THR ASP TYR SER LEU THR ILE SER ASN LEU SEQRES 7 L 212 GLU PRO GLU ASP ILE ALA THR TYR TYR CYS GLN GLN TYR SEQRES 8 L 212 GLU LYS LEU PRO TRP THR PHE GLY GLY GLY THR LYS LEU SEQRES 9 L 212 GLU VAL LYS ARG ALA ASP ALA ALA PRO THR VAL SER ILE SEQRES 10 L 212 PHE PRO PRO SER SER GLU GLN LEU THR SER GLY GLY ALA SEQRES 11 L 212 SER VAL VAL CYS PHE LEU ASN ASN PHE TYR PRO LYS ASP SEQRES 12 L 212 ILE ASN VAL LYS TRP LYS ILE ASP GLY SER GLU ARG GLN SEQRES 13 L 212 ASN GLY VAL LEU ASN SER TRP THR ASP GLN ASP SER LYS SEQRES 14 L 212 ASP SER THR TYR SER MET SER SER THR LEU THR LEU THR SEQRES 15 L 212 LYS ASP GLU TYR GLU ARG HIS ASN SER TYR THR CYS GLU SEQRES 16 L 212 ALA THR HIS LYS THR SER THR SER PRO ILE VAL LYS SER SEQRES 17 L 212 PHE ASN ARG ASN SEQRES 1 H 223 GLN VAL GLN LEU ALA GLU SER GLY PRO GLY LEU VAL ALA SEQRES 2 H 223 PRO SER GLN SER LEU SER ILE THR CYS THR VAL SER GLY SEQRES 3 H 223 PHE SER LEU THR ASP TYR GLY VAL ASP TRP VAL ARG GLN SEQRES 4 H 223 PRO PRO GLY LYS GLY LEU GLU TRP LEU GLY MET ILE TRP SEQRES 5 H 223 GLY ASP GLY SER THR ASP TYR ASN SER ALA LEU LYS SER SEQRES 6 H 223 ARG LEU SER ILE THR LYS ASP ASN SER LYS SER GLN VAL SEQRES 7 H 223 PHE LEU LYS MET ASN SER LEU GLN THR ASP ASP THR ALA SEQRES 8 H 223 ARG TYR TYR CYS VAL ARG ASP PRO ALA ASP TYR GLY ASN SEQRES 9 H 223 TYR ASP TYR ALA LEU ASP TYR TRP GLY GLN GLY THR SER SEQRES 10 H 223 VAL THR VAL SER SER ALA LYS THR THR PRO PRO SER VAL SEQRES 11 H 223 TYR PRO LEU ALA PRO GLY SER ALA ALA GLN THR ASN SER SEQRES 12 H 223 MET VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO SEQRES 13 H 223 GLU PRO VAL THR VAL THR TRP ASN SER GLY SER LEU SER SEQRES 14 H 223 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP SEQRES 15 H 223 LEU TYR THR LEU SER SER SER VAL THR VAL PRO SER SER SEQRES 16 H 223 THR TRP PRO SER GLU THR VAL THR CYS ASN VAL ALA HIS SEQRES 17 H 223 PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE VAL PRO SEQRES 18 H 223 ARG ASP SEQRES 1 A 196 MET TYR CYS SER ARG LEU LEU ASP LEU VAL PHE LEU LEU SEQRES 2 A 196 ASP GLY SER SER ARG LEU SER GLU ALA GLU PHE GLU VAL SEQRES 3 A 196 LEU LYS ALA PHE VAL VAL ASP MET MET GLU ARG LEU ARG SEQRES 4 A 196 ILE SER GLN LYS TRP VAL ARG VAL ALA VAL VAL GLU TYR SEQRES 5 A 196 HIS ASP GLY SER HIS ALA TYR ILE GLY LEU LYS ASP ARG SEQRES 6 A 196 LYS ARG PRO SER GLU LEU ARG ARG ILE ALA SER GLN VAL SEQRES 7 A 196 LYS TYR ALA GLY SER GLN VAL ALA SER THR SER GLU VAL SEQRES 8 A 196 LEU LYS TYR THR LEU PHE GLN ILE PHE SER LYS ILE ASP SEQRES 9 A 196 ARG PRO GLU ALA SER ARG ILE ALA LEU LEU LEU MET ALA SEQRES 10 A 196 SER GLN GLU PRO GLN ARG MET SER ARG ASN PHE VAL ARG SEQRES 11 A 196 TYR VAL GLN GLY LEU LYS LYS LYS LYS VAL ILE VAL ILE SEQRES 12 A 196 PRO VAL GLY ILE GLY PRO HIS ALA ASN LEU LYS GLN ILE SEQRES 13 A 196 ARG LEU ILE GLU LYS GLN ALA PRO GLU ASN LYS ALA PHE SEQRES 14 A 196 VAL LEU SER SER VAL ASP GLU LEU GLU GLN GLN ARG ASP SEQRES 15 A 196 GLU ILE VAL SER TYR LEU CYS ASP LEU ALA PRO GLU ALA SEQRES 16 A 196 PRO FORMUL 4 HOH *366(H2 O) HELIX 1 1 PRO L 80 ASP L 82 5 3 HELIX 2 2 SER L 122 SER L 127 1 6 HELIX 3 3 LYS L 183 ARG L 188 1 6 HELIX 4 4 SER H 275 LEU H 277 5 3 HELIX 5 5 ASN H 287 LYS H 289 5 3 HELIX 6 6 THR H 301 ASP H 303 5 3 HELIX 7 7 ASN H 378 GLY H 380 5 3 HELIX 8 8 SER H 408 THR H 410 5 3 HELIX 9 9 PRO H 423 SER H 425 5 3 HELIX 10 10 GLU A 527 ARG A 543 1 17 HELIX 11 11 PRO A 574 GLN A 583 1 10 HELIX 12 12 THR A 594 PHE A 603 1 10 HELIX 13 13 GLN A 628 SER A 631 1 4 HELIX 14 14 PHE A 634 LYS A 644 1 11 HELIX 15 15 LEU A 659 GLN A 668 1 10 HELIX 16 16 VAL A 680 LEU A 697 1 18 SHEET 1 A 2 SER L 10 ALA L 13 0 SHEET 2 A 2 LYS L 103 VAL L 106 1 N LYS L 103 O LEU L 11 SHEET 1 B 3 VAL L 19 SER L 24 0 SHEET 2 B 3 ASP L 70 ILE L 75 -1 N ILE L 75 O VAL L 19 SHEET 3 B 3 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 C 3 ALA L 84 GLN L 90 0 SHEET 2 C 3 LEU L 33 LYS L 39 -1 N GLN L 38 O THR L 85 SHEET 3 C 3 VAL L 44 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 D 4 THR L 114 PHE L 118 0 SHEET 2 D 4 GLY L 129 ASN L 137 -1 N ASN L 137 O THR L 114 SHEET 3 D 4 MET L 175 THR L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 D 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 E 4 SER L 153 ARG L 155 0 SHEET 2 E 4 ILE L 144 ILE L 150 -1 N ILE L 150 O SER L 153 SHEET 3 E 4 SER L 191 HIS L 198 -1 N THR L 197 O ASN L 145 SHEET 4 E 4 ILE L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 F 4 GLN H 217 SER H 221 0 SHEET 2 F 4 LEU H 232 SER H 239 -1 N SER H 239 O GLN H 217 SHEET 3 F 4 GLN H 291 MET H 296 -1 N MET H 296 O LEU H 232 SHEET 4 F 4 LEU H 281 ASP H 286 -1 N ASP H 286 O GLN H 291 SHEET 1 G 5 THR H 330 VAL H 332 0 SHEET 2 G 5 ALA H 305 ASP H 312 -1 N TYR H 307 O THR H 330 SHEET 3 G 5 GLY H 247 GLN H 253 -1 N GLN H 253 O ARG H 306 SHEET 4 G 5 GLU H 260 ILE H 265 -1 N ILE H 265 O VAL H 248 SHEET 5 G 5 THR H 271 TYR H 273 -1 N ASP H 272 O MET H 264 SHEET 1 H 3 MET H 358 VAL H 365 0 SHEET 2 H 3 LEU H 400 PRO H 407 -1 N VAL H 406 O VAL H 359 SHEET 3 H 3 VAL H 386 THR H 388 -1 N HIS H 387 O SER H 403 SHEET 1 I 3 THR H 374 TRP H 377 0 SHEET 2 I 3 THR H 417 HIS H 422 -1 N ALA H 421 O THR H 374 SHEET 3 I 3 THR H 427 LYS H 432 -1 N LYS H 431 O CYS H 418 SHEET 1 J 6 PHE A 675 LEU A 677 0 SHEET 2 J 6 VAL A 646 ILE A 653 1 N GLY A 652 O PHE A 675 SHEET 3 J 6 SER A 615 MET A 622 1 N ARG A 616 O ILE A 647 SHEET 4 J 6 LEU A 513 ASP A 520 1 N ASP A 514 O SER A 615 SHEET 5 J 6 VAL A 551 TYR A 558 1 N ARG A 552 O LEU A 513 SHEET 6 J 6 SER A 562 ILE A 566 -1 N ILE A 566 O VAL A 555 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS H 236 CYS H 309 1555 1555 2.03 SSBOND 4 CYS H 363 CYS H 418 1555 1555 2.03 SSBOND 5 CYS A 509 CYS A 695 1555 1555 2.04 CISPEP 1 LEU L 94 PRO L 95 0 -1.07 CISPEP 2 TYR L 140 PRO L 141 0 -0.44 CISPEP 3 PHE H 369 PRO H 370 0 0.13 CISPEP 4 GLU H 371 PRO H 372 0 0.04 CISPEP 5 TRP H 411 PRO H 412 0 0.68 CRYST1 208.200 61.900 72.900 90.00 108.60 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004803 0.000000 0.001616 0.00000 SCALE2 0.000000 0.016155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014473 0.00000